SHIDA Hiroaki

シダヒロアキ | SHIDA Hiroaki

Affiliation and department：
Other affiliations (1)：

Research field (2)： Clinical pharmacy , Clinical pharmacy

Research theme for competitive and other funds (5)：

Papers (5)：

内藤隆文, 柴田海斗, 志田拓顕, 阿部一樹, 川上純一. 抗体医薬のTDMの普及を志向したヒト血清中濃度測定の分析ワークフローの構築. 臨床薬理. 2020. 51. 3. 161-166
Hiroaki Shida, Takafumi Naito, Kaito Shibata, Yasuhide Yamada, Junichi Kawakami. LC-MS/MS method for denosumab quantitation in human serum with rapid protein digestion using immobilized trypsin. Bioanalysis. 2018. 10. 18. 1501-1510
Mayumi Sue, Nobuaki Higashi, Hiroaki Shida, Yusuke Kogane, Yoshio Nishimura, Hayamitsu Adachi, Elzbieta Kolaczkowska, Magdalena Kepka, Motowo Nakajima, Tatsuro Irimura. An iminosugar-based heparanase inhibitor heparastatin (SF4) suppresses infiltration of neutrophils and monocytes into inflamed dorsal air pouches. International immunopharmacology. 2016. 35. 15-21
Naoki Tsunekawa, Nobuaki Higashi, Yusuke Kogane, Michihiko Waki, Hiroaki Shida, Yoshio Nishimura, Hayamitsu Adachi, Motowo Nakajima, Tatsuro Irimura. Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines. Biochemical and biophysical research communications. 2016. 469. 4. 878-83
Nobuaki Higashi, Michihiko Waki, Mayumi Sue, Yusuke Kogane, Hiroaki Shida, Naoki Tsunekawa, Ahasanul Hasan, Takeshi Sato, Ayumi Kitahara, Tatsuhiko Kasaoka, et al. Heparanase-mediated cleavage of macromolecular heparin accelerates release of granular components of mast cells from extracellular matrices. The Biochemical journal. 2014. 458. 2. 291-9

MISC (11)：

第1回学位(博士)取得者のキャリアデザインに関するワークショップ報告書. 2023
平野美佳子, 志田拓顕, 栗田大輔, 平出貴乗. 主治医の倫理的葛藤に緩和ケアチームとしてどう関わるか? 患者の意思決定を支えるために. Palliative Care Research. 2020. 15. Suppl. S959-S959
平出貴乗, 栗田大輔, 市川太佑, 平野美佳子, 村松雅美, 志田拓顕, 柴田海斗, 堀雄史, 久保田綾乃, 須永訓子, et al. 当院におけるナルデメジンの使用状況と有効性の検討. Palliative Care Research. 2019. 14. Suppl. S246-S246
平出貴乗, 栗田大輔, 村松雅美, 平野美佳子, 志田拓顕, 望月洋介, 飯尾愛奈, 鈴木俊介, 深谷文香, 竹内裕也, et al. 当院における緩和ケアチームの変遷と今後の課題. Palliative Care Research. 2018. 13. Suppl. S517-S517
K. Shibata, T. Naito, H. Shida, J. Kawakam. VALIDATED LC-MS/MS METHOD FOR THE ABSOLUTE DETERMINATION OF CETUXIMAB IN HUMAN SERUM AND ITS CLINICAL APPLICATION. 2017 ASCPT Annual Meeting - American Society For Clinical Pharmacology And Therapeutics. 2017

ｍore...

Books (1)：

Lectures and oral presentations (7)：

がん患者における血清中デノスマブ濃度と内在性の血清タンパク質との関係解析
(日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大2019 2019)
Impact of endogenous serum immunoglobulin g on serum level of denosumab in cancer patients.
(14th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) 2019)
Development of a novel LC-MS/MS method for determination of denosumab in human serum and its clinical application to cancer patients.
(ASHP 2016 Midyear Meeting 2016)
定量的標的プロテオミクスによるデノスマブのヒト血清中濃度測定法の確立
(第 26 回医療薬学会年会 2016)
6 年制薬学教育の成果と今後の課題~ 6 年次生、卒業生、就職先からのフィードバック~
(日本薬学会第133年会 2013)

ｍore...

Education (2)：

2014 - 2019 Hamamatsu University School of Medicine Medical Sciences Graduate School
2007 - 2013 The University of Tokyo Faculty of Pharmaceutical Sciences Department of Pharmacy

Professional career (2)：

Work history (4)：

2023/09 - 現在 Juntendo University Faculty of Pharmacy
2023/01 - 現在 Juntendo University Department of Pharmacy, Juntendo University Hospital Pharmacist
2021/12 - 2022/12 Takeda Pharmaceutical Company Limited Drug Metabolism & Pharmacokinetics Research Laboratories, Preclinical & Translational Sciences, Research
2013/04 - 2021/11 Hamamatsu University School of Medicine Department of Hospital Pharmacy Pharmacist

Awards (3)：

2019/11 - 日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会ベストプレゼンテーション賞がん患者における血清中デノスマブ濃度と内在性の血清タンパク質との関係解析
2016/09 - 医療薬学会年会優秀演題賞定量的標的プロテオミクスによるデノスマブのヒト血清中濃度測定法の確立
2012 - 日本薬学会学生優秀発表賞好中球の血管外浸潤におけるヘパラナーゼの関与

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page